{"nctId":"NCT01040052","briefTitle":"A Study to Assess the Safety of Adacel® Vaccine","startDateStruct":{"date":"2009-12"},"conditions":["Diphtheria","Tetanus","Pertussis"],"count":30,"armGroups":[{"label":"Study Group","type":"EXPERIMENTAL","interventionNames":["Biological: Adacel® (Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis)"]}],"interventions":[{"name":"Adacel® (Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis)","otherNames":["Adacel®"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria :\n\n* Male or female (not pregnant) from 18-45 years of age.\n* Healthy, with no current illnesses.\n* Have not been immunized against diphtheria, pertussis and tetanus in the past 5 years.\n* Women of childbearing age will agree to use birth control during the study.\n* In good health, as verified by the following criteria: Heart rate, blood pressure, temperature and health history.\n* Able to understand and comply with requirements of the study.\n* A voluntary consent form is required before participating in the study.\n\nExclusion Criteria :\n\n* History of allergy to any ingredient in the vaccine.\n* A positive pregnancy test (for women of childbearing age) or women who are breastfeeding.\n* Compromised immune system due to treatment of a progressive disease.\n* Currently on oral or injected steroids, inhaled high-dosage steroids or other immunodeficiency or toxic drugs.\n* History of taking Immunoglobulin or other products during the 3 months prior to participating in the study.\n* Received other vaccines during the 4 months prior to participating in the study.\n* Has an acute or chronic condition that affects safety (including but not limited to: chronic liver disease, some kidney pathologies, progressive or unstabilized nerve disorders, diabetes and organ transplants).\n* Experienced a severe adverse event after receiving ADACEL® vaccine.\n* History of acute illness with temperatures over 37.5ºC during the week before receiving the vaccine.\n* Human immunodeficiency virus (HIV) infection.\n* History of alcohol or drug addiction during the past 5 years.\n* Plans to travel outside of the study area between shots and visits.\n* History of Guillain-Barré syndrome.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"45 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants Reporting at Least One Solicited Local or Systemic Reaction Post-Vaccination With ADACEL® Vaccine","description":"Solicited injection site reactions: Pain, itchiness, erythema (redness), and swelling. Solicited systemic reactions: Headache, body ache and muscle weakness, tiredness, chill, nausea, vomiting, rash, itchiness, anorexia, sore and swollen joints, diarrhea, lymph node swelling, and fever (temperature).","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"27","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":["Injection site pain","Tiredeness","Headache"]}}}